Pricing and Market Access in Partnering
Presented by Ralph Hughes, VP at PharmaVentures, the webinar looks at the importance of Market Access in Dealmaking.
What does this webinar address?
Market Access has a direct impact on the value of an asset and therefore impacts deal terms in any licensing deal. Companies often overlook Market Access of their drug candidates when looking for partners which puts them in a weak position when negotiating their deals.
Watch to learn the answers to the following
- What exactly is Market Access?
- Why is it important in the deal?
- How best to perform a Market Access study?
- What are the different components of the study?
- How does it impact clinical design and value?